EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy of novel endoscopic hemostatic agent for bleeding control and prevention: Results from a prospective, multicenter national registry

Roberta Maselli, Leonardo Da Rio, Mauro Manno, Paola Soriani, Gianluca Andrisani, Francesco Maria Di Matteo, Carlo Fabbri, Monica Sbrancia, Cecilia Binda, Alba Panarese, Fulvio D'Abramo, Teresa Staiano und 10 weitere

Endoscopy International Open · 01.10.2024 · 12 (10) · E1220-E1229

DOI: 10.1055/a-2406-7492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 01.10.2024. Verfasst von Roberta Maselli und 21 weiteren Autor:innen. Beteiligte Einrichtung: Endoscopy Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and study aims Topical hemostatic agents emerged as a new treatment modality for gastrointestinal bleeding. The aim of this study was to assess the safety and efficacy of PuraStat for control of active bleeding and for prevention of bleeding after different operative endoscopy procedures. Patients and methods A national, multicenter, observational registry was established to collect data from ten Italian centers from June 2021 to February 2023. Demographics, type of application (active gastrointestinal bleeding or prevention after endoscopic procedures, site, amount of gel used, completeness of coverage of the treated area), outcomes (rates of intraprocedural hemostasis and bleeding events during 30-day follow-up), and adverse events (AEs) were prospectively analyzed.

Results

Four hundred and one patients were treated for active gastrointestinal bleeding or as a preventive measure after different types of operative endoscopy procedures. Ninety-one treatments for active bleeding and 310 preventive applications were included. In 174 of 401 cases (43.4%), PuraStat was the primary treatment modality. Complete coverage was possible in 330 of 401 (82.3%) with difficulty in application in seven of 401 cases (1.7%). Hemostasis of active bleedings was achieved in 90 of 91 patients (98.9%). In 30-day follow-up 3.9% patients in whom PuraStat was used for prophylaxis had a bleeding event compared with 7.7% after hemostasis. No AEs related to the use of PuraStat were reported.

Conclusions

PuraStat is a safe and effective hemostat both for bleeding control and for bleeding prevention after different operative endoscopy procedures. Our results suggest that the possible applications for the use of PuraStat may be wider compared with current indications.

Schlagwörter

Stichwörter der Autor:innen

Endoscopic resection (ESD, EMRc, ...)Endoscopic resection (polypectomy, ESD, EMRc, ...)Endoscopy Lower GI TractEndoscopy Upper GI TractLower GI bleedingNon-variceal bleedingPerformance and complicationsQuality and logistical aspects

Autor:innen und Institutionen

  • Endoscopy Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Gastroenterology and Digestive Endoscopy Unit, Azienda USL Modena, Modena, Italy.
  • Digestive Endoscopy Unit, Campus Bio-Medico University, Rome, Italy.
  • Operative Endoscopy Department, Campus Bio-Medico University Hospital, Roma, Italy.
  • Gastroenterology and Digestive Endoscopy Unit, Forli-Cesena Hospitals, AUSL Romagna, Forlì Cesena, Italy.

ORCID-Profile: Renato Cannizzaro, Gianpiero Manes, Antonio Facciorusso, Cesare Hassan

Zitieren

APA

Maselli, R., Da Rio, L., Manno, M., Soriani, P., Andrisani, G., Di Matteo, F. M., Fabbri, C., Sbrancia, M., Binda, C., Panarese, A., D'Abramo, F., Staiano, T., Rizza, S., Cannizzaro, R., Maiero, S., Stigliano, V., de Nucci, G., Manes, G., Sacco, M., …, & Repici, A. (2024). Efficacy of novel endoscopic hemostatic agent for bleeding control and prevention: Results from a prospective, multicenter national registry. Endoscopy International Open, 12(10), E1220-E1229. https://doi.org/10.1055/a-2406-7492

Vancouver

Maselli R, Da Rio L, Manno M, Soriani P, Andrisani G, Di Matteo FM, et al. Efficacy of novel endoscopic hemostatic agent for bleeding control and prevention: Results from a prospective, multicenter national registry. Endoscopy International Open. 2024;12(10):E1220-E1229. doi:10.1055/a-2406-7492

BibTeX
@article{Maselli2024,
  author = {Maselli, Roberta and Da Rio, Leonardo and Manno, Mauro and Soriani, Paola and Andrisani, Gianluca and Di Matteo, Francesco Maria and Fabbri, Carlo and Sbrancia, Monica and Binda, Cecilia and Panarese, Alba and D'Abramo, Fulvio and Staiano, Teresa and Rizza, Stefano and Cannizzaro, Renato and Maiero, Stefania and Stigliano, Vittoria and de Nucci, Germana and Manes, Gianpiero and Sacco, Marco and Facciorusso, Antonio and Hassan, Cesare and Repici, Alessandro},
  title = {Efficacy of novel endoscopic hemostatic agent for bleeding control and prevention: Results from a prospective, multicenter national registry},
  journal = {Endoscopy International Open},
  year = {2024},
  volume = {12},
  number = {10},
  pages = {E1220--E1229},
  doi = {10.1055/a-2406-7492}
}
Kostenlos starten →